Search Results

The industry remains unwavering in the commitment to increased clinical trial accessibility and representation.

Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, announced it has acquired Norman, Oklahoma-based Bio-Cide International, Inc., a leading multi-specialty source of chlorine dioxide-based antimicrobial technology.

Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, with its subsidiary Kemin Biologics, has signed an exclusive agreement with Pacific GeneTech (PGT) to license PGT’s TMH001 Eimeria vaccine for poultry

Kemin, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, announced its Neumentix™ Phenolic Complex K110-42, a patent-pending spearmint extract containing a proprietary phenolic complex, has been approved by Health Canada, bringing the ingredient for brain health to consumers in Canada.

In a tough labor market where layoffs continue, some are considering—or even moving—from industry to academia, according to a BioSpace poll. A career coach, scientist and general practitioner turned research coordinator share their thoughts.

Donald Trump’s proposed tariffs on the EU would increase manufacturing costs for pharma companies and would stall medical innovation, according to the results of a recent survey by the Biotechnology Innovation Organization.